Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $916.17 | 21 | 98.9% |
| Education | $10.32 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $336.96 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $208.39 | 2 | $0 (2024) |
| Abbott Laboratories | $123.28 | 7 | $0 (2022) |
| HEARTFLOW, INC. | $116.29 | 2 | $0 (2024) |
| Boston Scientific Corporation | $55.76 | 3 | $0 (2024) |
| Cardiovascular Systems Inc. | $23.93 | 1 | $0 (2020) |
| iRhythm Technologies, Inc. | $20.07 | 1 | $0 (2020) |
| Lantheus Medical Imaging, Inc. | $18.54 | 1 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $12.75 | 1 | $0 (2018) |
| Maquet Cardiovascular U.S. Sales, L.L.C. | $10.52 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.67 | 4 | HEARTFLOW, INC. ($116.29) |
| 2023 | $324.96 | 4 | AstraZeneca Pharmaceuticals LP ($212.68) |
| 2022 | $45.03 | 2 | Abbott Laboratories ($45.03) |
| 2021 | $67.93 | 4 | Abbott Laboratories ($67.93) |
| 2020 | $184.12 | 4 | AstraZeneca Pharmaceuticals LP ($124.28) |
| 2018 | $23.27 | 2 | PORTOLA PHARMACEUTICALS, INC. ($12.75) |
| 2017 | $32.51 | 2 | BOSTON SCIENTIFIC CORPORATION ($22.19) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $83.33 | General |
| Category: Coronary | ||||||
| 05/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/08/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $32.96 | General |
| Category: Coronary | ||||||
| 02/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $114.65 | General |
| Category: Cardiovascular | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $91.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2023 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CONTRAST AGENT | ||||||
| 02/02/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $93.74 | General |
| Category: Cardiovascular | ||||||
| 06/02/2022 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Vascular | ||||||
| 01/11/2022 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Vascular | ||||||
| 08/20/2021 | Abbott Laboratories | Perclose ProGlide suture mediated closure system (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Vascular | ||||||
| 07/13/2021 | Abbott Laboratories | Perclose ProGlide suture mediated closure system (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Vascular | ||||||
| 07/02/2021 | Abbott Laboratories | Supera peripheral stent system (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Vascular | ||||||
| 03/11/2021 | Abbott Laboratories | Perclose ProGlide suture mediated closure system (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Vascular | ||||||
| 10/01/2020 | Cardiovascular Systems Inc. | Coronary Orbital Atherectomy System (Device) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: Atherectomy Device | ||||||
| 09/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: STRUCTURAL HEART | ||||||
| 06/12/2020 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 01/10/2018 | Maquet Cardiovascular U.S. Sales, L.L.C. | iCAST (Device) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/01/2017 | BOSTON SCIENTIFIC CORPORATION | THE LATITUDE PATIENT MANAGEMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: TACHY HF | ||||||
| 02/14/2017 | Abbott Laboratories | CRM-Research only (Device) | Education | Cash or cash equivalent | $10.32 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,249 | 1,459 | $176,147 | $69,883 |
| 2022 | 16 | 1,231 | 1,468 | $166,470 | $64,634 |
| 2021 | 15 | 959 | 1,128 | $138,404 | $57,275 |
| 2020 | 14 | 887 | 1,005 | $136,504 | $51,973 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 105 | 213 | $40,044 | $19,006 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 216 | $39,960 | $17,737 | 44.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 257 | 260 | $36,400 | $12,662 | 34.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 65 | $15,730 | $6,127 | 39.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 53 | 53 | $7,685 | $2,741 | 35.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 38 | $5,320 | $2,247 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,400 | $1,785 | 40.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 299 | 332 | $6,640 | $1,746 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $3,125 | $1,511 | 48.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $2,736 | $970.20 | 35.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 63 | 63 | $3,654 | $888.11 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $2,220 | $821.81 | 37.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 63 | 63 | $2,646 | $608.34 | 23.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 33 | 33 | $3,300 | $597.08 | 18.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 36 | $1,440 | $349.22 | 24.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 11 | 11 | $737.00 | $60.17 | 8.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 11 | 11 | $110.00 | $25.85 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 292 | $54,020 | $24,163 | 44.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 213 | 219 | $31,392 | $10,899 | 34.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 108 | $20,304 | $8,174 | 40.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 53 | 54 | $13,068 | $5,414 | 41.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 69 | $9,660 | $3,569 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $6,050 | $2,426 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 48 | $6,000 | $2,339 | 39.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 39 | 39 | $5,655 | $2,210 | 39.1% |
About Dr. Subhashish Pal, M.D
Dr. Subhashish Pal, M.D is a Cardiovascular Disease healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386753952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Subhashish Pal, M.D has received a total of $926.49 in payments from pharmaceutical and medical device companies, with $248.67 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($916.17).
As a Medicare-enrolled provider, Pal has provided services to 4,326 Medicare beneficiaries, totaling 5,060 services with total Medicare billing of $243,764. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Latrobe, PA
- Active Since 08/29/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386753952
Products in Payments
- FARXIGA (Drug) $245.64
- CAMZYOS (Drug) $208.39
- FFRct (Device) $116.29
- BRILINTA (Drug) $91.32
- Perclose ProGlide suture mediated closure system (Device) $51.60
- PERCLOSE PROGLIDE (Device) $45.03
- Coronary Orbital Atherectomy System (Device) $23.93
- THE LATITUDE PATIENT MANAGEMENT SYSTEM (Device) $22.19
- ZIO Patch (Device) $20.07
- DEFINITY (Drug) $18.54
- WATCHMAN FLX (Device) $17.73
- Supera peripheral stent system (Device) $16.33
- WATCHMAN (Device) $15.84
- BEVYXXA (Drug) $12.75
- iCAST (Device) $10.52
- CRM-Research only (Device) $10.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Latrobe
Mark Milchak, Md, MD
Cardiovascular Disease — Payments: $8,261
Simon Chough, Md, MD
Cardiovascular Disease — Payments: $3,263
Abid Fakhri, M.d, M.D
Cardiovascular Disease — Payments: $1,593
Salman Bhatti, M.d, M.D
Cardiovascular Disease — Payments: $1,506
Edward Szabo
Cardiovascular Disease — Payments: $708.40
Dr. Robert Staffen, Md, MD
Cardiovascular Disease — Payments: $313.17